The Future of Regenerative Medicine: Secretome Science, Stem Cells, Peptides, and the Reality of Access in the US

Most people first hear "regenerative medicine" and picture stem cells. The field has moved well past that, and the distance between what the research shows and what patients can access is narrowing quickly.

In this webinar, Healthspan Collective Founder Elias Arjan sits down with Sanjiv Lal, CEO & Co-Founder of Regen Therapy, and Regen Therapy Chief Longevity Officer Dr. Arvind Chakravarthy for a conversation about where regenerative and longevity medicine stand today, and where they're heading.

The discussion covers:

• What regenerative medicine means, and how it differs from managing symptoms
• The move from stem cells to exosomes to secretome science, and the case Lal and Dr. Arvind make for why the secretome does much of the work
• Acute versus chronic inflammation, and why root cause matters for long-term health
• What patients can access in the US right now, including PRP, state-by-state stem cell availability, and the cost and insurance realities behind it
• How quantum cell factors compare to peptides like BPC-157
• Why foundational health comes first: sleep, nutrition, movement, and mindset before any advanced protocol
• Quality control and third-party lab verification, and why transparency is the real test for this space

A grounded, practical conversation for clinicians and curious individuals who want longevity science made legible, without the hype.